Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Antibiotics for Tunneled Catheters in Hemodialysis
NCT06814223Phase 4Recruiting
- Sponsor
- Galilee Medical Center
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Modality
- Reversible Covalent Inhibitors, Nanoparticles, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin and gentamicin in Catheter-related infection (CRI) (2 arms), sponsored by Galilee Medical Center. Primary endpoint: Early catheter-related infection at 45 days. Started Oct 2024; status: recruiting.
02
Drugs
cefazolingentamicin
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT06814223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06814223.